SANOFI-AVENTIS U.S. LLC v. MYLAN LABORATORIES LIMITED
3:15-cv-03392
Overview
Parties
Defendant
MYLAN LABORATORIES LIMITED NPE (University / Research)
Represented By
0 Attorneys ListedPlaintiff
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Neptune Generics, LLC et al. v. Aventis Pharma S.A. et al.
Mylan Laboratories Limited et al. v. Aventis Pharma S.A. et al.
Sanofi-Aventis U.S. LLC v. Apotex Corp.
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA LLC
SANOFI-AVENTIS U.S. LLC v. ACCORD HEALTHCARE, INC.
SANOFI-AVENTIS U.S. LLC v. FRESENIUS KABI USA, LLC
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5847170
Taxoids, their preparation and pharmaceutical compositions containing them
|
Filed: 1996-03-26
Issued: 1998-12-08
|
Expired (Term Ended)
+1826d PTA
Expires: 2021-03-26
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
High PTA (+1826 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).